Semaglutide and Type 2 Diabetes Contact Hours: 2 Author(s): Maureen Sullivan-Tevault RN, BSN, CEN, CDCES Course Highlights In this course, you will learn about the mechanisms and clinical applications of GLP-1 injectable medications, specifically semaglutide, in managing Type 2 diabetes and its associated health risks
Jastreboff AM et al., SURMOUNT-1, NEJM 2022 (NEJMoa2206038) : tirzepatide up to 15 mg, loss -22,5% at 72 weeks
Semaglutide GLP-1 is part of a class of drugs known as glucagon-like-peptide 1 receptor antagonists, or simply GLP-1 receptor antagonists
If you are already on a GLP-1 medication from another provider, you can maintain your current dose with documentation of your prior prescription
Safety is conditional upon the peptide